Showing results (2451-2460 of 25,162) with videos related to

Sort By:
Pageof 2,517
Oncotarget|May 7, 2017
Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach?Jiaqiang Zhang, Jiabin Jin, Shi Chen, et al.
Oncotarget|May 7, 2017
Characterization of potential driver mutations involved in human breast cancer by computational approachesBarani Kumar Rajendran, Chu-Xia Deng
Oncotarget|May 10, 2017
Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsisFan-Yen Lee, Kuan-Hung Chen, Christopher Glenn Wallace, et al.
Oncotarget|May 11, 2017
A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17Chun-Nan Yeh, Ming-Huang Chen, Yen-Yang Chen, et al.
Oncotarget|May 11, 2017
Relationship between exposure to PM2.5 and lung cancer incidence and mortality: A meta-analysisFeifei Huang, Bing Pan, Jun Wu, et al.
Oncotarget|May 11, 2017
Naoling decoction restores cognitive function by inhibiting the neuroinflammatory network in a rat model of Alzheimer's diseaseZian Xia, Weijun Peng, Shunhua Cheng, et al.
Oncotarget|May 11, 2017
Programmed death-1 polymorphisms is associated with risk of esophagogastric junction adenocarcinoma in the Chinese Han population: A case-control study involving 2,740 subjectsWeifeng Tang, Shuchen Chen, Yu Chen, et al.
Oncotarget|May 11, 2017
Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysisLejia Sun, Gang Xu, Wenjun Liao, et al.
Oncotarget|May 11, 2017
YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitorSheng Dong, Xiang Ma, Zusen Wang, et al.
Oncotarget|May 11, 2017
Eg5 inhibitor YL001 induces mitotic arrest and inhibits tumor proliferationYufei Wang, Xingyu Wu, Mufeng Du, et al.
Pageof 2,517